42 results
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
and Corporate Governance Committee’s policy that the composition of the Board of Directors reflect a range of talents, ages, skills, character, diversity … individual’s role, responsibilities, skills, and experience. Base salaries are typically reviewed annually, with any increases normally taking effect
10-K
2023 FY
EX-10.30
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
-how, technology, means, methods, processes, practices, formulae, instructions, skills, techniques, procedures, ideas, technical assistance, designs … , protocols, manufacturing techniques, operating manuals, databases, formulas, knowledge, trade secrets, technologies, processes, assays, sources, skills
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
role, responsibilities, skills, and experience. Base salaries are typically reviewed annually, with any increases normally taking effect from the first
6-K
EX-99.2
MREO
Mereo Biopharma Group Plc
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am
the return on investment.
Mereo’s Board has been thoughtfully composed and refreshed to ensure an optimal and diverse combination of skills, experience … combination of skills, experience and expertise, particularly related to strategic partnerships and M&A, to best position Mereo to advance our most
6-K
EX-99.1
MREO
Mereo Biopharma Group Plc
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am
Refreshed Board, which has the Right Skills and Experience to Guide Mereo’s Strategy and Maximize Shareholder Value
Details Rubric’s Rejection
6-K
EX-99.1
bqc0a1z
3 Oct 22
Mereo BioPharma Confirms Receipt of a Valid Notice Requiring it to Convene a General Meeting of Shareholders
5:43pm
6-K
EX-99.1
qcw 0k4inp9dmrqsyhl
31 Aug 22
Letter Reiterates Mereo’s Updated Strategic Plan to Maximize Value for All Shareholders and Corrects Rubric’s Assumptions
7:57am
424B5
qudl92x668wpt a6dv
10 Feb 21
Prospectus supplement for primary offering
4:53pm
424B5
14h093d tf
9 Feb 21
Prospectus supplement for primary offering
5:24pm
424B5
poxrc27b0
23 Oct 20
Prospectus supplement for primary offering
4:40pm
F-3
0mwi 40vgb461
6 Oct 20
Shelf registration (foreign)
4:25pm